PPT-MM: HCV and Cirrhosis Patient Case

Chris Kolkman PrimaryOne Health Meet MM Patient Background MM is a 59yearold Hispanic female who presents for a regular health checkup accompanied by her daughter to help translate CC I would like to establish care here in the US and to have someone manage my diabetes and cirrhosis. Associate Professor of Medicine. Division of . Gastroenterology. /Hepatology. University of Utah Health Sciences Center. Referral for Liver Transplantation Evaluation. Last . Updated: . September . 3. Kelsey Conrad. Annelise. . Chmelik. September 24, 2013. the . Liver. Largest organ in the body. Extremely complex organ. Filters harmful substances from the blood. Makes substances that digests food. Associate Professor of Medicine. Division of . Gastroenterology. /Hepatology. University of Utah Health Sciences Center. Referral for Liver Transplantation Evaluation. Last . Updated: . September . 3. Richa Shukla. Faculty mentor: Dr. Sahil Mittal. February 12, 2015. Case discussion. Reason for presentation: Abdominal pain. 41F with medical history significant for HLD, HTN and DM. Presented to ED with 6 months of waxing and waning RUQ pain, worse over 3-4 weeks prior to presentation. Best of ILC 2018. About these slides. These slides provide highlights of new data presented at the International Liver Congress 2018. Please feel free to use, adapt, and share these slides for your own personal use; however, please acknowledge EASL as the source. Terry D. Box, MD Associate Professor of Medicine Division of Gastroenterology /Hepatology University of Utah Health Sciences Center Referral for Liver Transplantation Evaluation Last Updated: September Efficacy and Safety of Glecaprevir / Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: The EXPEDITION-2 Study Jürgen K Rockstroh 1 , Karine Lacombe disease. Penny North-Lewis. Paediatric Liver Pharmacist. Leeds . Children’s Hospital. September 2019. Where is the liver?. What does the liver do?. Synthesis. . (e.g. albumin & clotting . factors, cholesterol). Kings College Hospital London UK. . 20–50%. . <1.0%. . 2–3%. . 7–8%. . 3–5%. . 2–6% for HBeAg+. . 20–50%. <0.2%. . 8–10% for HBeAg-. HBV-related liver disease progression. Richa Shukla. Faculty mentor: Dr. Sahil Mittal. February 12, 2015. Case discussion. Reason for presentation: Abdominal pain. 41F with medical history significant for HLD, HTN and DM. Presented to ED with 6 months of waxing and waning RUQ pain, worse over 3-4 weeks prior to presentation. DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA. . DR. R MANE. TOPICS DISCUSSED : . Hepatic encephalopathy. Spontaneous bacterial peritonitis. Hepatorenal. syndrome. Hepatopulmonary. syndrome. 211 Corresponding author: PORTAbbreviationsCRP – C-Reactive ProteinCT – Computer Tomography JOLOGY – VOLUME XVIII, N. 4, 2019 212 exhibited bilateral cerebellar-parkinsonian tremor and leural occur in 5% to 10% of patients with cirrhosis of the liver (1 ). In these patients, ascites is usually evident but a pleural effusion may develop in a cirrhotic patient in the absence ofdetecta Nicholas Lim, MD. Associate Professor of Medicine. Alaska Tribal Health Webinar Series. May 5. th. 2022. Disclosures. No Financial Relationships. No Discussion of Off-label Medication Use or Investigational Drugs.